News
Human liver rebuilt in 3D

Human liver tissue has been reconstructed in 3D at a cellular level, revealing how cirrhosis alters the organ’s internal structure compared with healthy tissue.
The 3D reconstructions capture the fine-scale microstructure of multiple liver lobes and show how scarring disrupts biological activity inside the organ.
Cirrhosis is extensive scarring of the liver caused by long-term damage from viral infection, metabolic disorders, certain medicines or alcohol misuse.
A healthy liver performs more than 500 essential functions, including detoxification, metabolism, digestion, nutrient storage, blood clotting and immune defence.
Kelly Stevens is professor of bioengineering at the UW School of Medicine and the UW College of Engineering, and a senior author of the research.
She said: “Our field has skimmed over a fact that could prevent this dream from becoming reality: We do not know what complex organs look like at a cellular level.
“We do not yet have the ‘blueprints’ of human organs to feed into bioprinters.
“This oversight is important because decades of studies have shown that the structure of human organs, particularly the organ-specific topology of its vasculature, is intimately connected to organ function.
“If the maps are not right, the organs produced will not be functional.”
The work was carried out by engineers and physicians at UW Medicine and the University of Washington, who developed what they describe as the Liver Map pipeline.
Tissue samples were taken from patients who had parts of their liver removed during cancer surgery or who underwent liver transplantation, including samples from cirrhotic livers.
The causes of cirrhosis varied across the samples.
Through the reconstructions, the researchers identified several structural changes linked to cirrhosis.
These included disrupted transport of metabolites in the sinusoidal zones of liver lobes, a reduction in specialised cells that help lower toxic ammonia levels, regression of central vein networks, disruption of artery networks and fragmentation of the bile network, which carries the fluid used to digest fats.
Taken together, the findings point to a broader shift in the liver’s vascular network, meaning the system of blood vessels that supports circulation within the organ.
The team also views the work as a step towards developing replacement organs.
Organ bioprinting is an emerging effort to use 3D printers to build living tissue layer by layer from cells and biomaterials to create organs or partial replacements for transplantation.
The researchers highlighted a key limitation.
The current imaging approach cannot yet capture the full depth of a human liver lobule, the hexagonal units that make up the organ, though they expect this to be addressed as the technology advances.
News
AI can predict Alzheimer’s with almost 93% accuracy, researchers say

Alzheimer’s AI can predict the disease with nearly 93 per cent accuracy using more than 800 brain scans, researchers say.
The system identified anatomical changes in the brain linked to the onset of the most common form of dementia, a condition that gradually damages memory and thinking.
The findings build on years of research suggesting AI could help spot early Alzheimer’s risk, predict disease and identify patients whose condition has not yet been diagnosed.
Benjamin Nephew, an assistant research professor at the Worcester Polytechnic Institute in Massachusetts, said: “Early diagnosis of Alzheimer’s disease can be difficult because symptoms can be mistaken for normal ageing.
“We found that machine-learning technologies, however, can analyse large amounts of data from scans to identify subtle changes and accurately predict Alzheimer’s disease and related cognitive states.”
The study used MRI scans, a type of detailed brain imaging, from 344 people aged 69 to 84.
The dataset included 281 scans showing normal mental function, 332 with mild cognitive impairment, an early stage of memory and thinking decline, and 202 with Alzheimer’s.
The scans covered 95 of the brain’s nearly 200 distinct regions and used an AI algorithm to predict patients’ health.
Being able to use AI to help diagnose Alzheimer’s earlier could give patients and doctors crucial time to prepare and potentially slow the progression of the disease.
The analysis showed that one of the top predictive factors was brain volume loss, or shrinkage, in the hippocampus, which helps form memories, the amygdala, which processes fear, and the entorhinal cortex, which helps provide a sense of time.
This pattern held across age and sex, with both men and women aged 69 to 76 showing volume loss in the right part of the hippocampus, suggesting it may be an important area for early diagnosis, the researchers noted.
However, the research also found that the way brain regions shrink differs by sex.
In females, volume loss occurred in the brain’s left middle temporal cortex, which is involved in language and visual perception. In males, it was mainly seen in the right entorhinal cortex
The researchers believe this could be linked to changes in sex hormones, including the loss of oestrogen in women and testosterone in men.
These conclusions could help improve methods of diagnosis and treatment going forward, Nephew said.
More than 7.2m Americans are living with Alzheimer’s, according to the Alzheimer’s Association.
More research is being done to reveal other impacting factors.
Nephew said: “The critical challenge in this research is to build a generalisable machine-learning model that captures the difference between healthy brains and brains from people with mild cognitive impairment or Alzheimer’s disease.”
News
Vision implant firm raises US$230m
News
Radiology AI may improve workflows

Radiology AI may improve workflows and patient care, but the technology also brings challenges for radiology departments, research suggests.
A focus issue from the Journal of the American College of Radiology brings together invited research and reviews exploring how AI is being used across different practice types.
Barriers include insufficient infrastructure, strict institutional regulations and a lack of insurance reimbursement, all of which can hamper the integration of AI into routine clinical workflows.
Radiology, the branch of medicine that uses imaging such as X-rays and scans to diagnose and treat disease, is widely seen as one of the fields most likely to be reshaped by AI.
The research includes contributions arguing that workflow improvement is not simply a secondary benefit of AI, but a main determinant of whether a tool succeeds.
Gelareh Sadigh, associate editor for health services research at the Journal of the American College of Radiology, said: “When thoughtfully implemented, AI can complement human expertise and improve efficiency and patient care.
“Successful workflow optimisation requires the integration of AI technology into routine workflows.
“This can be hampered by insufficient infrastructure, strict institutional regulations, and lack of insurance reimbursement.
“Poor integration of AI may degrade workflows, satisfaction, and safety and perpetuate bias in healthcare.”
According to Dr Sadigh, the articles in the focus issue reflect a broader shift in radiology: workflow is not a secondary benefit of AI, but a key factor in whether a tool is successful.
If AI is going to meaningfully help radiology, it must make care delivery better and not more complicated.
Ruth C. Carlos, editor-in-chief of the Journal of the American College of Radiology, said: “This focus issue provides meaningful signposts for AI effectiveness as we navigate a rapidly shifting landscape.”
Insights2 weeks agoInterview: The US company appealing Europe’s rejection of daily Alzheimer’s pill
News4 weeks agoLongevity startup Biopeak raises US$2.7m
News4 weeks agoBryan Johnson launches US$1m longevity programme
News4 weeks agoAgetech investment & innovation round-up
News4 weeks agoInterview: Dr Matthew Bennett on building resilience and a pain-free healthspan
News2 weeks agoCentenarians’ blood reveals longevity clues
Wellness4 weeks agoRe:Cognition and Cera expand Alzheimer’s clinical trials access
News4 weeks agoFrench biotech raises €12m for osteoarthritis trial
















